Related Experiment Video
Updated: Nov 10, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Proven Fatal Invasive Aspergillosis in a Patient with COVID-19 and Staphylococcus aureus Pneumonia
Frank van Someren Gréve1, Romy du Long2, Raju Talwar3
1Department of Medical Microbiology, Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands.
Abstract:
There is increasing attention for opportunistic pathogens such as Aspergillus fumigatus complicating SARS-CoV-2 infections in the critically ill. For invasive fungal disease, establishing a clear diagnosis can be challenging due to the invasiveness of diagnostic procedures required for a proven case. Here we present one of the first proven cases of COVID-19-associated pulmonary aspergillosis by positive culture of post-mortem lung biopsy.
Insights
Opportunistic fungal infections like Aspergillus fumigatus are a concern in severe COVID-19. This case confirms COVID-19-associated pulmonary aspergillosis via post-mortem lung biopsy culture.
Area of Science:
- Mycology
- Infectious Diseases
- Pulmonology
Background:
- Rising incidence of opportunistic fungal infections complicating severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in critically ill patients.
- Challenges in diagnosing invasive fungal diseases due to the need for invasive procedures for definitive diagnosis.
Observation:
- A critically ill patient with SARS-CoV-2 infection developed complications.
- Diagnostic procedures for invasive fungal disease can be invasive and challenging.
Findings:
- This report details one of the first proven cases of COVID-19-associated pulmonary aspergillosis.
- Diagnosis was confirmed by positive culture of *Aspergillus fumigatus* from a post-mortem lung biopsy.
Implications:
- Highlights the importance of considering invasive aspergillosis in SARS-CoV-2 patients.
- Post-mortem lung biopsy is a valuable tool for confirming invasive pulmonary aspergillosis in complex cases.
- Underscores the diagnostic challenges and potential severity of co-infections in critically ill COVID-19 patients.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Fungal Phylum Ascomycota
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: